Member Info for ajc2

His wife is also now a director at Carbon Theory alongside other ex Revolution colleagues. I've noticed Carbon Theory appearing in some of the same distributors as Revolution. Free to do whatever now the settlement agreement is signed.

Must be some serious video editing happening!!

Currently trading on 7.5x EBITDA. Undervalued as we speak.

Share price overreaction to the low single digit turnover growth comment. Investors (more likely traders) selling out and missing the point about rationalisation of lower margin business and focus on better margins. Looks like they have steadied the business over the last year and returned to trading profitably, now reset to focus on profitable sales growth. Playing out like a typical turnaround story now in my view, just need to show some profitable growth going forward for the market to catch on.

They didn't lose their cash by Revb going into admin, and weren't forced to sell at the price they did, it was entirely their choice.

There should be a trading update soon. Something positive for the institutional investors to digest prior to the capital market event.

No not one reply. Retail investors do not appear to be of interest at the moment. Hopefully the business is still growing and we will get an update soon. It was always the concern when Boohoo took control of the board.

They did also say January, but maybe they meant 2025!

Boohoo will be kept fully up to date, that's all that seems to matter!

UK retail sales data shows decline -3.2% in December versus Card Factory store revenue growth +7.8%. That's good performance.

Regarding the national minimum wage increase, Card are well placed to deal with this imo. There wage bill last year was £138m. Let's assume they apply a 10% wage increase to the entire wage bill, this would equate to £13.8m wage expense increase. On at least £476m turnover, they would need to raise prices around 3% across the board to cover this. In other words increase the price of a card from £1.50 to £1.55, hardly noticeable to the consumer.

Card have the advantage of supplying low cost products in high volume, so can pass price increases minimally per unit. Or as they did last year, via targeted price increases.

I'm still bullish on Card however note the potential headwinds. Once the dividend is re-introduced (whenever that may be), this share should garner more interest from investors and re-rate.

Nice. Whereabouts has this been confirmed?

CARD have already proved they can manage wage increases (last year I think it was 9.7%) through price increases, efficiencies etc. so not ideal, but not a big concern.

Clinton's are closing 38 stores.. should benefit CARD

I understand the covenant related loan was due to be paid off this month.

Is the Capital Markets Event they said would happen in January going ahead?

I think Lake leaving will also be as a result of the negotiations with Minto and Allsworth. Minto at least voted against her at the AGM. Boohoo have had opportunities to remove her but didn't so I think this will be a mutual agreement. She has done well and been rewarded.

I still believe Minto is trying to negotiate a future role at the business, which I dont believe is in REVBs best interest. FCA would likely agree. Disappointing REVB is now controlled by Boohoo, and to some extent Minto and Allsworth. But as Lake has stated, the business is profitable.

I sold down some shares yesterday morning as I wasn't happy with the settlement agreement

and to derisk / re -balance the portfolio, but still believe the business has much potential, if everything is genuine.

TA must be a far better negotiator than Boohoo!

Struggling to make sense of this Settlement agreement and how we've gone from overpaying for Medichem to paying their legal fees? Plus the new revised payment terms means it could take 14 years before TA gets the full balance based on current numbers!!! Unless there is a takeover...

Going back though the independant investigation and revaluation of Medichem found that Revolution were basically buying product third party products through Medichem at a marked up price to boost Medichems profits in the years prior to being acquired (at least £350k pa).. products that Revolution previously bought direct from suppliers therefore increasing the valuation. All in TA's interest. Agree this is positive for cash flow but once again feel previous directors are getting off lightly.

So no revised valuation of Medichem and now we are paying TA legal fees and giving him a future role within the business? Shocking.

Can't wait for Minto's settlement agreement and future role within the business to be announced.

Disappointed to see Elizabeth Lake go.

At least the business has some more headroom in terms of finances.